Under construction – not a live service
Sign in
Not yet taking people in GermanyNo phase

European Registry Collects Long-Term Data From People With Tuberculosis

Collects information on tuberculosis patients across Europe, including treatment, side effects and outcomes.

Plain-language title generated from the registry record
Registry title: Tuberculosis Clinical Registry in Europe

Key facts

Where
Borstel, GermanySee the site

Where in Germany

  • Research Center Borstel, Leibniz Lung CenterBorstel, GermanyNo longer taking part

Questions to ask the study team

  1. How often do I need to come in, and for how long each time?
  2. Are travel costs paid?
  3. Can I keep my own doctor?
  4. What happens if I want to stop?
Print a page for my doctor

Trial details

Who runs it
Research Center Borstel
Trial code
NCT07677904
Record updated
1 July 2026
Original description
The TBnet registry is a multinational, prospective tuberculosis registry established by the Tuberculosis Network European Trialsgroup (TBnet e.V.) to collect and analyze long-term data from TB patients across Europe. Its purpose is to centralize data on TB epidemiology, prevention, diagnosis, and treatment to improve care, support research, and ultimately help eliminate TB. The registry captures risk factors, diagnostic details (e.g., microbiology, imaging, drug resistance), treatment data, side effects, outcomes, and late complications.Read full original descriptionShow less

Tuberculosis Clinical Registry in Europe - the TBnet Registry

The TBnet registry is a multinational, prospective tuberculosis registry established by the Tuberculosis Network European Trialsgroup (TBnet e.V.) to collect and analyze long-term data from TB patients across Europe. Its purpose is to centralize data on TB epidemiology, prevention, diagnosis, and treatment to improve care, support research, and ultimately help eliminate TB. The registry captures risk factors, diagnostic details (e.g., microbiology, imaging, drug resistance), treatment data, side effects, outcomes, and late complications.

Inclusion: Diagnosis of Tuberculosis; Age ≥ 18 years; Capacity to provide informed consent; Written informed consent to participate in the study.

Exclusion: Age < 18 years; Lack of capacity to provide informed consent.

ClinicalTrials.gov NCT07677904